These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 20639901

  • 1. Janus kinase 2 is required for the initiation but not maintenance of prolactin-induced mammary cancer.
    Sakamoto K, Triplett AA, Schuler LA, Wagner KU.
    Oncogene; 2010 Sep 30; 29(39):5359-69. PubMed ID: 20639901
    [Abstract] [Full Text] [Related]

  • 2. A non-catalytic function of the Src family tyrosine kinases controls prolactin-induced Jak2 signaling.
    García-Martínez JM, Calcabrini A, González L, Martín-Forero E, Agulló-Ortuño MT, Simon V, Watkin H, Anderson SM, Roche S, Martín-Pérez J.
    Cell Signal; 2010 Mar 30; 22(3):415-26. PubMed ID: 19892015
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Autocrine prolactin promotes prostate cancer cell growth via Janus kinase-2-signal transducer and activator of transcription-5a/b signaling pathway.
    Dagvadorj A, Collins S, Jomain JB, Abdulghani J, Karras J, Zellweger T, Li H, Nurmi M, Alanen K, Mirtti T, Visakorpi T, Bubendorf L, Goffin V, Nevalainen MT.
    Endocrinology; 2007 Jul 30; 148(7):3089-101. PubMed ID: 17412813
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Impaired alveologenesis and maintenance of secretory mammary epithelial cells in Jak2 conditional knockout mice.
    Wagner KU, Krempler A, Triplett AA, Qi Y, George NM, Zhu J, Rui H.
    Mol Cell Biol; 2004 Jun 30; 24(12):5510-20. PubMed ID: 15169911
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Targeting janus kinase 2 in Her2/neu-expressing mammary cancer: Implications for cancer prevention and therapy.
    Sakamoto K, Lin WC, Triplett AA, Wagner KU.
    Cancer Res; 2009 Aug 15; 69(16):6642-50. PubMed ID: 19638583
    [Abstract] [Full Text] [Related]

  • 10. Constitutive activation of JAK2 in mammary epithelium elevates Stat5 signalling, promotes alveologenesis and resistance to cell death, and contributes to tumourigenesis.
    Caffarel MM, Zaragoza R, Pensa S, Li J, Green AR, Watson CJ.
    Cell Death Differ; 2012 Mar 15; 19(3):511-22. PubMed ID: 21941370
    [Abstract] [Full Text] [Related]

  • 11. Diphenylbutylpiperidine Antipsychotic Drugs Inhibit Prolactin Receptor Signaling to Reduce Growth of Pancreatic Ductal Adenocarcinoma in Mice.
    Dandawate P, Kaushik G, Ghosh C, Standing D, Ali Sayed AA, Choudhury S, Subramaniam D, Manzardo A, Banerjee T, Santra S, Ramamoorthy P, Butler M, Padhye SB, Baranda J, Kasi A, Sun W, Tawfik O, Coppola D, Malafa M, Umar S, Soares MJ, Saha S, Weir SJ, Dhar A, Jensen RA, Thomas SM, Anant S.
    Gastroenterology; 2020 Apr 15; 158(5):1433-1449.e27. PubMed ID: 31786131
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Interactions among Janus kinases and the prolactin (PRL) receptor in the regulation of a PRL response element.
    Gao J, Hughes JP, Auperin B, Buteau H, Edery M, Zhuang H, Wojchowski DM, Horseman ND.
    Mol Endocrinol; 1996 Jul 15; 10(7):847-56. PubMed ID: 8813725
    [Abstract] [Full Text] [Related]

  • 14. PRL/PRLR Can Promote Insulin Resistance by Activating the JAK2/STAT5 Signaling Pathway.
    Wang PY, Jin CC, Liu C, Zhao ZJ, Yang HY.
    Comput Math Methods Med; 2022 Jul 15; 2022():1456187. PubMed ID: 36238467
    [Abstract] [Full Text] [Related]

  • 15. The role of prolactin receptor in GH signaling in breast cancer cells.
    Xu J, Sun D, Jiang J, Deng L, Zhang Y, Yu H, Bahl D, Langenheim JF, Chen WY, Fuchs SY, Frank SJ.
    Mol Endocrinol; 2013 Feb 15; 27(2):266-79. PubMed ID: 23192981
    [Abstract] [Full Text] [Related]

  • 16. Prolactin induces up-regulation of its cognate receptor in breast cancer cells via transcriptional activation of its generic promoter by cross-talk between ERα and STAT5.
    Kavarthapu R, Tsai Morris CH, Dufau ML.
    Oncotarget; 2014 Oct 15; 5(19):9079-91. PubMed ID: 25193864
    [Abstract] [Full Text] [Related]

  • 17. Janus kinase 2 (JAK2) regulates prolactin-mediated chloride transport in mouse mammary epithelial cells through tyrosine phosphorylation of Na+-K+-2Cl- cotransporter.
    Selvaraj NG, Omi E, Gibori G, Rao MC.
    Mol Endocrinol; 2000 Dec 15; 14(12):2054-65. PubMed ID: 11117534
    [Abstract] [Full Text] [Related]

  • 18. The prolactin receptor mediates HOXA1-stimulated oncogenicity in mammary carcinoma cells.
    Hou L, Xu B, Mohankumar KM, Goffin V, Perry JK, Lobie PE, Liu DX.
    Int J Oncol; 2012 Dec 15; 41(6):2285-95. PubMed ID: 23064471
    [Abstract] [Full Text] [Related]

  • 19. Induction of multidrug resistance transporter ABCG2 by prolactin in human breast cancer cells.
    Wu AM, Dalvi P, Lu X, Yang M, Riddick DS, Matthews J, Clevenger CV, Ross DD, Harper PA, Ito S.
    Mol Pharmacol; 2013 Feb 15; 83(2):377-88. PubMed ID: 23150485
    [Abstract] [Full Text] [Related]

  • 20. The last proline of Box 1 is essential for association with JAK2 and functional activation of the prolactin receptor.
    Pezet A, Buteau H, Kelly PA, Edery M.
    Mol Cell Endocrinol; 1997 May 16; 129(2):199-208. PubMed ID: 9202403
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.